heart-diseases-2017-scientifictracks-abstracts

4 / 14

Page 19
Notes:
alliedacademies
Curr Trend Cardiol. 2017 | Volume 1 Issue 3
September 18-19, 2017 | Toronto, Canada
Annual Conference on
HEART DISEASES
Traditional risk assessment for coronary artery disease
(CAD) using coronary risk factors has been refined with
the selective use of coronary artery calcium (CAC). This is
possible because CAC is pathognomonic of atherosclerosis,
and a histological study showed its close correlation with the
atherosclerotic plaque burden. The severity of CAC can be
easily quantified by electron beam computed tomography
(CT) or multi-detector CT (MDCT). CAC is currently a useful
marker of subclinical CAD and an independent predictor
of cardiovascular events. CAD is a risk factor for HF, but
information on the association of CAC scores with HF is still
lacking. It is possible that measuring CAC score may identify
patients at high risk for heart failure. In this session, I will
review clinical significance of measuring CAC score in the
setting of cardiovascular disease. Also, I will discuss about
the future of assessing CAC score.
Speaker Biography
Satoru Sakuragi, MD, PhD, is an expert in the diagnosis and treatment of cardiovascular
diseases, including hypertension, dyslipidemia, atherosclerosis, peripheral arterial
disease, and coronary artery disease. He graduated Okayama University Medical
School in 1992. He subsequently completed his residency of cardiology at Okayama
University Hospital. Then, he obtained his PhD from Okayama University Graduate
School of Medicine. After that, he had studied at the Canberra Hospital in Australia
as a clinical research fellow for two years. He is a board-certificated physician of the
Japanese Cardiology Society, the Japanese Society of Internal Medicine, the Japanese
Association of Cardiac Rehabilitation, and the Japanese Association of Cardiovascular
Intervention and Therapeutics. He is also a fellow of the Japanese college of Cardiology
and the European Society of Cardiology. Dr. Sakuragi is currently the chief of Dep. Of
Cardiovascular medicine at Iwakuni Clinical Hospital, Yamaguchi, Japan. His clinical
interests include the diagnosis and treatment of ischemic heart diseases. He has
especially focused on non-invasive assessment of atherosclerosis and coronary artery
disease. He is actively involved in cutting edge research and has published his work
in prestigious journals as well as presented his work at several national Cardiology
meetings.
e:
Significant association of coronary artery calcification with heart failure in patients without a history
of coronary artery disease
Satoru Sakuragi
Iwakuni Clinical Center, Japan